Adequacy of thyroid hormone replacement in a general population

QJM: An International Journal of Medicine

Volumn 104, Issue 5, 2011, Pages 395-401

  Okosieme, O E ^a   Belludi, G ^a   Spittle, K ^a   Kadiyala, R ^a   Richards, J ^b  

^a PRINCE CHARLES HOSPITAL   (United Kingdom)

^b Morlais Medical Practice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ADULT; AGED; ARTICLE; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; GENDER; HEALTH; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; REGISTER; RETROSPECTIVE STUDY; THYROID FUNCTION TEST; THYROID GLAND; THYROTROPIN BLOOD LEVEL;

EID: 79953104717     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq222     Document Type: Article

References (24)

1. Vaidya B, Pearce SH. Management of hypothyroidism in adults. BMJ 2008; 337:a801.
2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160:526-34.
3. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87:489-99.
4. Somwaru LL, Arnold AM, Joshi N, Fried LP, Cappola AR. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 2009; 94:1342-5.
5. Baron DN. Hypothyroidism; its aetiology and relation to hypometabolism, hypercholesterolaemia, and increase in body-weight. Lancet 1956; 271:277-81.
6. Duntas LH. Thyroid disease and lipids. Thyroid 2002; 12:287-93.
7. Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocrinol Metab 2002; 87:1996-2000.
8. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331:1249-52.
9. Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab 2010; 95:186-93.
10. Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990; 13:265-9.
11. Paul TL, Kerrigan J, Kelly AM, Braverman LE, Baran DT. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 1988; 259:3137-41.
12. Morris JC. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clin Endocrinol 2009; 70:671-3.
13. Investing in general practice. The new general medical services contract. British Medical Association 2007. Annexe A: Quality indicators - Hypothyroidism. [http://www.bma.org.uk/employmentandcontracts/independent_contractors/general_medical_services_contract/investinggp.jsp?page=9] Accessed 1 September 2010.
14. De Whalley P. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice. Br J Gen Pract 1995; 45:93-5.
15. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 1993; 43:107-9.
16. Viswanath AK, Avenell A, Philip S, Acharya SH, Maclennan G, Dalziel K, et al. Is annual surveillance of all treated hypothyroid patients necessary? BMC Endocr Disord 2007; 7:4.
17. Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol 2001; 54(Suppl. 1):S57-60.
18. Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract 2010; 64:1130-9.
19. StatsWales. [http://www.statswales.wales.gov.uk]. Accessed 31 August 2010.
20. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29:76-131.
21. Dugbartey AT. Neurocognitive aspects of hypothyroidism. Arch Intern Med 1998; 158:1413-8.
22. Díez JJ. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy. J Gerontol A Biol Sci Med Sci 2002; 57:M315-20.
23. Bolk N, Visser TJ, Kalsbeek A, van Domburg RT, Berghout A. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin Endocrinol 2007; 66:43-8.
24. Rangan S, Tahrani AA, Macleod AF, Moulik PK. Once weekly thyroxine treatment as a strategy to treat non-compliance. Postgrad Med J 2007; 83:e3.